Intramyocardial bone marrow mononuclear cells versus bone marrow-derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy

被引:14
|
作者
Dolores Carmona, M. [1 ,2 ,3 ]
Canadillas, Sagrario [1 ,2 ,3 ]
Romero, Miguel [1 ,3 ,4 ]
Blanco, Alfonso [5 ]
Nogueras, Sonia [1 ,2 ,3 ]
Herrera, Concha [1 ,2 ,3 ,6 ]
机构
[1] Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain
[2] Reina Sofia Univ Hosp, Cellular Therapy Unit, Ave Menendez Pidal S-N, Cordoba 14004, Spain
[3] Univ Cordoba, Cordoba, Spain
[4] Reina Sofia Univ Hosp, Cardiol Dept, Cordoba, Spain
[5] Univ Cordoba, Anat & Comparat Pathol Dept, Cordoba, Spain
[6] Reina Sofia Univ Hosp, Hematol Dept, Cordoba, Spain
关键词
animal model; dilated cardiomyopathy; growth factor; myocardial fibers organization; neovascularization; stem cell transplantation; STEM-CELLS; STROMAL CELLS; HEART-FAILURE; TRANSPLANTATION; TRIAL; INFUSION; THERAPY;
D O I
10.1016/j.jcyt.2017.05.006
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background. Effects of cell therapy on dilated cardiomyopathy (DCM) have been investigated in pre-clinical models using distinct cellular types in each study. A single study that compares the effectiveness of different cells is lacking. Methods. We have compared the effects of intramyocardial injection (IMI) of bone marrow (BM)-derived mononuclear cells (MNCs), BM and adipose tissue (AT) mesenchymal stromal cells (BM-MSCs and AT-MSCs) on heart function, histological changes and myocardial ultrastructure in a rat model of DCM. Isogenic Wistar rats were used to isolate the different cell types and to induce DCM by autoimmune myocarditis. Animals were randomly assigned to receive BM-MNCs, BM-MSCs, AT-MSCs or placebo at day 42 by IMI. Serial echocardiography was used to assess cardiac function and hearts obtained after sacrifice at day 70, were used for histological and ultrastructural analysis. Serum levels of type B-natriuretic peptide (BNP) and vascular endothelial growth-factor (VEGF) were determined at different time points. Results. BM-MSC treatment induced significant improvement in ejection fraction (EF), fractional shortening (FS), left ventricular systolic diameter (LVESD) and systolic volume (LVESV). In contrast, changes in echocardiographic parameters with respect to pre-treatment values in animals receiving placebo, AT-MSCs or BM-MNCs were not statistically significant. EF and FS in animals receiving AT-MSCs were superior to those receiving placebo. BM-MSC transplantation induced also improvement in cardiac fibers organization and capillary density, fibrotic tissue reduction, increase in final VEGF concentration and BNP decrease. Discussion. IMI of BM or AT-MSCs improves LV function and induces more angiogenesis processes than BM-MNCs. In addition, BM-MSCs showed more anti-fibrotic effects and more ability to reorganize myocardial tissue compared with the other cell types.
引用
收藏
页码:947 / 961
页数:15
相关论文
共 50 条
  • [1] Bone marrow-derived mesenchymal stem cells versus bone marrow nucleated cells in the treatment of chondral defects
    Zhang, Yi
    Wang, Fuyou
    Chen, Jiarong
    Ning, Zhigang
    Yang, Liu
    INTERNATIONAL ORTHOPAEDICS, 2012, 36 (05) : 1079 - 1086
  • [2] Bone marrow-derived mesenchymal stem cells versus bone marrow nucleated cells in the treatment of chondral defects
    Yi Zhang
    Fuyou Wang
    Jiarong Chen
    Zhigang Ning
    Liu Yang
    International Orthopaedics, 2012, 36 : 1079 - 1086
  • [3] Intramyocardial administration of autologous bone marrow mononuclear cells in a critically ill child with dilated cardiomyopathy
    Lacis, Aris
    Erglis, Andrejs
    CARDIOLOGY IN THE YOUNG, 2011, 21 (01) : 110 - 112
  • [4] Bone marrow-derived mesenchymal stem cells
    Kemp, KC
    Hows, J
    Donaldson, C
    LEUKEMIA & LYMPHOMA, 2005, 46 (11) : 1531 - 1544
  • [5] Effects of adipose and bone marrow-derived mesenchymal stem cells on vaginal atrophy in a rat menopause model
    Kasap, Burcu
    Kasap, Sukru
    Vatansever, Seda
    Kendirci, Remziye
    Yilmaz, Osman
    Calisir, Meryem
    Edgunlu, Tuba
    Akin, Melike Nur
    GENE, 2019, 711
  • [6] Effective intramyocardial implantation of autologous bone marrow-derived mononuclear cells in patients with end stage ischemic cardiomyopathy
    Chandrinou, H.
    Protogeros, D.
    Danou, F.
    Trikka, C.
    Prapas, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 368 - 368
  • [7] Comparative analysis of canine mesenchymal stem cells and bone marrow-derived mononuclear cells
    Maeta, Noritaka
    Tamura, Katsutoshi
    Ezuka, Fuuna
    Takemitsu, Hiroshi
    VETERINARY WORLD, 2021, 14 (04) : 1028 - 1037
  • [8] Bone marrow-derived mesenchymal stem cells versus adipose-derived mesenchymal stem cells for peripheral nerve regeneration
    Fernandes, Marcela
    Valente, Sandra Gomes
    Sabongi, Rodrigo Guerra
    Gomes dos Santos, Joao Baptista
    Leite, Vilnei Mattioli
    Ulrich, Henning
    Nery, Arthur Andrade
    da Silva Fernandes, Maria Jose
    NEURAL REGENERATION RESEARCH, 2018, 13 (01) : 100 - 104
  • [9] Bone marrow-derived mesenchymal stem cells versus adipose-derived mesenchymal stem cells for peripheral nerve regeneration
    Marcela Fernandes
    Sandra Gomes Valente
    Rodrigo Guerra Sabongi
    Jo?o Baptista Gomes dos Santos
    Vilnei Mattioli Leite
    Henning Ulrich
    Arthur Andrade Nery
    Maria José da Silva Fernandes
    NeuralRegenerationResearch, 2018, 13 (01) : 100 - 104
  • [10] Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy
    Chin, Sze-Piaw
    Poey, Alfred C.
    Wong, Chee-Yin
    Chang, Sau-Kong
    Tan, Chiang-Soo
    Mei-Theng Ng
    Chew, Kee-Hock
    Lam, Kai-Huat
    Cheong, Soon-Keng
    CYTOTHERAPY, 2011, 13 (07) : 814 - 821